Not yet recruitingPhase 4NCT07357103

Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)

Studying Pneumocystosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Principal Investigator
Emily G McDonald, MD MSc
McGill University Health Centre/Research Institute of the McGill University Health Centre
Intervention
Clindamycin + primaquine(drug)
Enrollment
416 enrolled
Eligibility
18 years · All sexes
Timeline
2026 – 2029

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07357103 on ClinicalTrials.gov

Other trials for Pneumocystosis

Additional recruiting or active studies for the same condition.

See all trials for Pneumocystosis →

← Back to all trials